Single-dose pharmacokinetics and safety of daclatasvir in subjects with renal function impairment
Single-dose pharmacokinetics and safety of daclatasvir in subjects with renal function impairment. Antivir Ther. 2015;20(5):535-543. .
Publication Type:
Journal ArticleSource:
Antivir Ther, Volume 20, Issue 5, p.535-543 (2015)Notes:
Epub 2015 Feb 5.